Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30024753HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS30024754HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS30024755HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20031395HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20048477HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20047262HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20047848HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20042271HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TCGA Plot Options
Drug Information
GeneKCND3
DrugBank IDDB06217
Drug NameVernakalant
Target IDBE0003604
UniProt IDQ9UK17
Regulation Typeblocker
PubMed IDs
CitationsDia E.Q., Rathbun R.A., Song J.C.: Vernakalant: A novel antiarrhythmic agent for the treatment of atrial fibrillation Formulary. 2007 August 1;42:475-483.
GroupsApproved; Investigational
Direct ClassificationTyrosols and derivatives
SMILESCOC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL2111112